| Daniel N Curri, DPT | |
|
152 N Main St, Herkimer, NY 13350-2041 | |
| (315) 717-0020 | |
| (315) 717-0024 |
| Full Name | Daniel N Curri |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 152 N Main St, Herkimer, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134371495 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 030601 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Daniel N Curri, DPT 152 N Main St, Herkimer, NY 13350-2041 Ph: (315) 717-0020 | Daniel N Curri, DPT 152 N Main St, Herkimer, NY 13350-2041 Ph: (315) 717-0020 |
News Archive
Enzo Biochem Inc. announced today that favorable results of the Company's clinical trial for treatment of non-alcoholic steatohepatitis (NASH) were presented at the annual meeting of the American Association for the Study of Liver Diseases. The study was a randomized double blind placebo controlled format of EGS21, Enzo's orally administered beta glucosylceramide formulation, designed to evaluate safety and efficacy of the study drug in patients with NASH and its associated metabolic syndrome.
Outside of Asia, Denmark became the first nation to ease the forced social distancing norms or lockdown. Last week on Thursday, the officials declared that since the removal of the lockdown, there had been no rise in the number of COVID-19 cases. Their easing of the lockdown rules has been gradual, say the officials, and this process began in mid-April. There have been 9,721 reported cases and 484 deaths due to COVID-19 to date. The number of cases has also declined since 7th April.
Drug discovery is in essence the designing of compounds to interact with disease-related proteins. And in many recent development efforts, this process increasingly relies on "big data" and complex "deep learning", requiring the harnessing of supercomputing power.
The President and CEO of Three Rivers Pharmaceuticals, Donald J. Kerrish, RPh., stated, "The approval of Ribasphere™ marks a milestone in the treatment of HCV. Ribasphere™ is positioned to break down the economic barriers that have existed for the past decade in treating this chronic and potentially deadly disease." Traditionally the cost of treatment for HCV can range from $20,000 – $25,000 annually. "Our aim is to bring affordable medicine to all individuals infected with this dreadful disease." Mr. Kerrish continued.
› Verified 7 days ago
Blase Thomas Pachura, Physical Therapist Medicare: Medicare Enrolled Practice Location: 3061 State Route 28, Herkimer, NY 13350 Phone: 315-717-0020 | |
Shawna Marmet, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3061 State Route 28, Herkimer, NY 13350 Phone: 315-717-0020 | |
Sheila M Burth, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 419 N Main St, Herkimer, NY 13350 Phone: 315-717-0278 Fax: 315-717-0280 | |
Jared Tripoli, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3061 State Route 28, Herkimer, NY 13350 Phone: 315-717-0022 Fax: 315-717-0024 | |
Rebekah Jean Sirtoli White, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3061 State Route 28, Herkimer, NY 13350 Phone: 315-717-0020 Fax: 315-717-0024 | |
Tom Woznica, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3061 State Route 28, Herkimer, NY 13350 Phone: 315-717-0020 Fax: 315-717-0024 |